The Centers for Medicare & Medicaid Services seeks input through May 29 on ways to strengthen Medicare Advantage data to guide policymaking and advance transparency. The request for information, which builds on a similar request in 2022, particularly expresses interest in data recommendations related to: beneficiary access to care, including provider directories and networks; prior authorization and utilization management, including care denials, appeals processes and use of algorithms; cost and use of supplemental benefits; MA marketing and consumer decision-making; care quality and outcomes; the impact of mergers, acquisitions and vertical integration; and special populations, such as individuals dually eligible for Medicare and Medicaid or with complex conditions.

AHA has urged CMS to hold MA plans accountable for inappropriately restricting beneficiary access to medically necessary care, including in comments responding to the 2022 RFI and recent comments on MA proposals for contract year 2025, which include recommendations on improving data collection and reporting necessary to conduct appropriate oversight of the MA program. 

Related News Articles

Headline
The Government Accountability Office May 29 released a report recommending the Centers for Medicare & Medicaid Services target behavioral health services…
Headline
The Centers for Medicare & Medicaid Services May 21 announced it will immediately begin annual audits of all Medicare Advantage plans and work to clear a…
Headline
Leaders from the Centers for Medicare & Medicaid Services at the 2025 AHA Annual Membership Meeting May 5 discussed issues on the agency’s agenda in a…
Headline
The AHA April 30 released a report highlighting how hospitals and health systems continue to experience significant financial headwinds that can challenge…
News
The Centers for Medicare & Medicaid Services April 7 released finalized payment rates for calendar year 2026 Medicare Advantage and Part D plans. Payments…
Headline
The Centers for Medicare & Medicaid Services April 4 finalized changes to the Medicare Advantage and prescription drug programs for contract year 2026. The…